To view the PDF file, sign up for a MySharenet subscription.

LABAT AFRICA LIMITED - Director Appointment and Change in Role

Release Date: 14/04/2020 16:54
Code(s): LAB     PDF:  
Wrap Text
Director Appointment and Change in Role

(Incorporated in the Republic of South Africa)
(Registration number 1986/001616/06)
(“Labat Africa” or “the Company”)
ISIN Code: ZAE 000018354 Share code: LAB


The Board of Labat Africa (“Board”) is pleased to announce the appointment of Mr Mike Stringer
(“Mike”) as an executive director on to the Board of Directors.

During 2019, Mike joined Labat Africa through the acquisition of The Highly Creative Proprietary
Limited as announced last year. Mike was appointed as the Managing Director to head up the
Labat Healthcare operations and will now join the Board to help drive the growth strategy,
particularly into the cannabis and hemp industries, which he has researched for over six years.

Mike has over 30 years’ experience in the Active Pharmaceutical Ingredients (“API”) industry and
has operated in both the USA and European Union. He was the former CEO for a leading Cape
Town based API Manufacturer in South Africa. Together with his API experience, Mike has a wealth
of experience in both the regulatory and Pharma technical fields as well as an extensive network,
both locally and internationally. Mike has completed an Executive Leadership Programme (UCT)
and an MBA in Leadership and Sustainability (UK).

The Board would like to announce that Mr Ntabeni Tebogo Mogapi has stepped down as an
Executive Director of Labat Africa. He will, however, remain as a non-executive director of the

By order of the board

14 April 2020

Arbor Capital Sponsors Proprietary Limited

Date: 14-04-2020 04:54:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story